Risk-based Monitoring Software Market by End User (Pharma & Biopharmaceutical Co., Medical Device Co., CROs), Delivery Mode (Web Hosted, On-premise, Cloud-based), Type (Enterprise, Site), Component (Software, Services) - Global Forecast to 2025
“Risk-based monitoring (RBM) software market is projected to grow at a CAGR of 13.3%.”
The RBM software market is expected to reach USD 511 million by 2025 from USD 273 million in 2020, at a CAGR of 13.3% during the forecast period. The RBM software market has witnessed various advancements in products and their approvals to meet the needs of the pharmaceutical research and development industry worldwide.
Growth in the market can primarily be attributed to factors such as the cost and time efficiency of RBM solutions, rising number of clinical trials, and increasing government funding and grants to support clinical trials
“The Enterprise RBM Software segment to hold the largest market share in 2020.”
Based on type, the RBM software market is segmented into Enterprise RBM Software and Site RBM Software. In 2020, the Enterprise RBM Software segment is expected to command the largest share of the RBM software market. The large share of this segment can be attributed to the widespread adoption of enterprise RBM software by end-users as it allows all authorized professionals to have access to clinical trial data and metrics placed at a centralized location.
“The software component segment to hold the largest market share in 2020.”
Based on the component, the RBM software market is segmented into Software and Services. In 2020, the software segment is expected to command the largest share of the RBM software market. The large share of this segment can be attributed to the increasing R&D expenditure in the life science and clinical research industries, increasing number of clinical trials, and rising customer base
“The pharmaceutical and biopharmaceutical companies segment to hold the largest market share in 2020.”
Based on end-user, the RBM software market is segmented into pharmaceutical and biopharmaceutical companies, CROs, medical device companies, and other end users. In 2020, the pharmaceutical and biopharmaceutical companies segment is expected to command the largest share of the RBM software market. The increasing R&D expenditure of pharmaceutical and biopharmaceutical companies is the major factor driving the growth of this end-user segment.
“The Asia Pacific region to witness the highest growth during the forecast period.”
Geographically, North America dominated the global RBM software market in 2020. However, the Asia Pacific market is expected to register the highest during the forecast period. The major factors driving the growth of the Asia Pacific market include increasing government funding to support clinical trials, the presence of less stringent regulatory guidelines as compared to developed nations, a large patient base, low operating costs for conducting clinical trials, shortage of trial volunteers in Europe and North America, and the growing number of pharmaceutical companies and CROs in the region.
Break of primary participants was as mentioned below:
Research Coverage
This report studies the RBM software market based on type, component, delivery mode, end-user, and region. The report also studies the different factors (such as drivers, restraints, challenges, and opportunities) affecting the market growth. It analyzes the opportunities and challenges in the market and provides details of the competitive landscape for market leaders. Furthermore, the report analyzes micromarkets with respect to their individual growth trends and forecasts the revenue of the market segments with respect to four main regions and respective countries.
Key Benefits of Buying the Report
This report focuses on various levels of analysis—industry trends, market shares of top players, and company profiles, which together form basic views and analyze the competitive landscape, emerging segments of the RBM software market, and their drivers, restraints, and opportunities. The report will help both established firms as well as new entrants/smaller firms to gauge the pulse of the RBM software and garner greater market shares.
The RBM software market is expected to reach USD 511 million by 2025 from USD 273 million in 2020, at a CAGR of 13.3% during the forecast period. The RBM software market has witnessed various advancements in products and their approvals to meet the needs of the pharmaceutical research and development industry worldwide.
Growth in the market can primarily be attributed to factors such as the cost and time efficiency of RBM solutions, rising number of clinical trials, and increasing government funding and grants to support clinical trials
“The Enterprise RBM Software segment to hold the largest market share in 2020.”
Based on type, the RBM software market is segmented into Enterprise RBM Software and Site RBM Software. In 2020, the Enterprise RBM Software segment is expected to command the largest share of the RBM software market. The large share of this segment can be attributed to the widespread adoption of enterprise RBM software by end-users as it allows all authorized professionals to have access to clinical trial data and metrics placed at a centralized location.
“The software component segment to hold the largest market share in 2020.”
Based on the component, the RBM software market is segmented into Software and Services. In 2020, the software segment is expected to command the largest share of the RBM software market. The large share of this segment can be attributed to the increasing R&D expenditure in the life science and clinical research industries, increasing number of clinical trials, and rising customer base
“The pharmaceutical and biopharmaceutical companies segment to hold the largest market share in 2020.”
Based on end-user, the RBM software market is segmented into pharmaceutical and biopharmaceutical companies, CROs, medical device companies, and other end users. In 2020, the pharmaceutical and biopharmaceutical companies segment is expected to command the largest share of the RBM software market. The increasing R&D expenditure of pharmaceutical and biopharmaceutical companies is the major factor driving the growth of this end-user segment.
“The Asia Pacific region to witness the highest growth during the forecast period.”
Geographically, North America dominated the global RBM software market in 2020. However, the Asia Pacific market is expected to register the highest during the forecast period. The major factors driving the growth of the Asia Pacific market include increasing government funding to support clinical trials, the presence of less stringent regulatory guidelines as compared to developed nations, a large patient base, low operating costs for conducting clinical trials, shortage of trial volunteers in Europe and North America, and the growing number of pharmaceutical companies and CROs in the region.
Break of primary participants was as mentioned below:
- By Company Type: Tier I: 55%, Tier II: 25%, Tier III: 20%
- By Designation: C-Level Executives: 35%, Directors: 25%, Others: 40%
- By Region: North America: 20%, Europe: 25%, Asia Pacific : 40%, RoW: 15%
Research Coverage
This report studies the RBM software market based on type, component, delivery mode, end-user, and region. The report also studies the different factors (such as drivers, restraints, challenges, and opportunities) affecting the market growth. It analyzes the opportunities and challenges in the market and provides details of the competitive landscape for market leaders. Furthermore, the report analyzes micromarkets with respect to their individual growth trends and forecasts the revenue of the market segments with respect to four main regions and respective countries.
Key Benefits of Buying the Report
This report focuses on various levels of analysis—industry trends, market shares of top players, and company profiles, which together form basic views and analyze the competitive landscape, emerging segments of the RBM software market, and their drivers, restraints, and opportunities. The report will help both established firms as well as new entrants/smaller firms to gauge the pulse of the RBM software and garner greater market shares.
1 INTRODUCTION
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.2.1 MARKET SCOPE
1.2.2 MARKETS COVERED
1.2.3 YEARS CONSIDERED FOR THE STUDY
1.3 CURRENCY
1.4 LIMITATIONS
1.5 STAKEHOLDERS
2 RESEARCH METHODOLOGY
2.1 RESEARCH DATA
2.1.1 SECONDARY DATA
2.1.1.1 Secondary sources
2.1.2 PRIMARY DATA
2.1.2.1 Primary sources
2.1.3 MARKET SIZE ESTIMATION METHODOLOGY
2.1.4 REVENUE MAPPING-BASED MARKET ESTIMATION (APPROACH 1)
2.1.5 MARKET ESTIMATION USING PARENT MARKET SIZE (APPROACH 2)
2.2 MARKET DATA ESTIMATION AND TRIANGULATION
2.3 ASSUMPTIONS OF THE STUDY
3 EXECUTIVE SUMMARY
4 PREMIUM INSIGHTS
4.1 RISK-BASED MONITORING SOFTWARE: MARKET OVERVIEW
4.2 RISK-BASED MONITORING SOFTWARE MARKET SHARE, BY TYPE, 2020 VS. 2025
4.3 RISK-BASED MONITORING SOFTWARE MARKET SHARE, BY COMPONENT, 2020 VS. 2025
4.4 RISK-BASED MONITORING SOFTWARE MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES
5 MARKET OVERVIEW
5.1 INTRODUCTION
5.2 MARKET DYNAMICS
5.2.1 DRIVERS
5.2.1.1 Cost and time efficiency of RBM solutions
5.2.1.2 Rising number of clinical trials
5.2.1.3 Increasing government funding and grants to support clinical trials
5.2.2 RESTRAINTS
5.2.2.1 High implementation costs
5.2.3 OPPORTUNITIES
5.2.3.1 Increased outsourcing of clinical trial processes to CROs
5.2.4 CHALLENGES
5.2.4.1 Dearth of skilled professionals for operating RBM solutions
6 RISK-BASED MONITORING SOFTWARE MARKET, BY TYPE
6.1 INTRODUCTION
6.2 ENTERPRISE RBM SOFTWARE
6.2.1 ENTERPRISE RBM SOFTWARE DOMINATES THE RBM SOFTWARE MARKET
6.3 SITE RBM SOFTWARE
6.3.1 SITE RBM SOFTWARE OFFERS IMPROVED TRIAL MANAGEMENT
7 RISK-BASED MONITORING SOFTWARE MARKET, BY COMPONENT
7.1 INTRODUCTION
7.2 SOFTWARE
7.2.1 GROWING ADOPTION OF CLINICAL TRIAL MANAGEMENT SOLUTIONS TO SUPPORT MARKET GROWTH
7.3 SERVICES
7.3.1 NEED FOR CONTINUOUS UPGRADE OF RBM SOFTWARE PRODUCTS HAS INCREASED THE DEMAND FOR SERVICES
8 RISK-BASED MONITORING SOFTWARE MARKET, BY DELIVERY MODE
8.1 INTRODUCTION
8.2 WEB-BASED (ON-DEMAND)
8.2.1 ADVANTAGES SUCH AS EASY ACCESS & REDUCTION IN COSTS TO SUPPORT MARKET GROWTH
8.3 LICENSED ENTERPRISE (ON-PREMISE)
8.3.1 ON-PREMISE MODELS MINIMIZE RISKS ASSOCIATED WITH DATA BREACHES AND EXTERNAL ATTACKS
8.4 CLOUD-BASED (SAAS)
8.4.1 INCREASING ADOPTION OF CLOUD-BASED SOLUTIONS TO DRIVE MARKET GROWTH
9 RISK-BASED MONITORING SOFTWARE MARKET, BY END USER
9.1 INTRODUCTION
9.2 PHARMACEUTICAL & BIOPHARMACEUTICAL COMPANIES
9.2.1 INCREASED PHARMACEUTICAL R&D SPENDING TO DRIVE MARKET GROWTH
9.3 CONTRACT RESEARCH ORGANIZATIONS (CROS)
9.3.1 INCREASING OUTSOURCING OF CLINICAL RESEARCH ACTIVITIES
BY PHARMACEUTICAL, BIOTECHNOLOGY, AND MEDICAL DEVICE COMPANIES TO DRIVE MARKET GROWTH
9.4 MEDICAL DEVICE COMPANIES
9.4.1 GOVERNMENT FUNDING TO SUPPORT MARKET GROWTH
9.5 OTHER END USERS
10 RISK-BASED MONITORING SOFTWARE MARKET, BY REGION
10.1 INTRODUCTION
10.2 NORTH AMERICA
10.2.1 US
10.2.1.1 The US holds the largest share of the North American market
10.2.2 CANADA
10.2.2.1 Government funding to boost market growth
10.3 EUROPE
10.3.1 GERMANY
10.3.1.1 Initiatives to boost digital health to propel market growth
10.3.2 UK
10.3.2.1 Favorable R&D scenario in the country to boost the adoption of
RBM software
10.3.3 FRANCE
10.3.3.1 Lack of sufficient funding to restrain market growth in France
10.3.4 ROE
10.4 APAC
10.4.1 CHINA
10.4.1.1 Increased pharmaceutical R&D spending to drive market growth
10.4.2 JAPAN
10.4.2.1 Stringent regulatory scenario in Japan to restrain market growth
10.4.3 INDIA
10.4.3.1 Favorable pharmaceutical R&D scenario to drive the adoption of RBM software
10.4.4 REST OF ASIA PACIFIC
10.5 REST OF THE WORLD
11 COMPETITIVE LANDSCAPE
11.1 OVERVIEW
11.2 MARKET SHARE ANALYSIS
11.3 COMPETITIVE LEADERSHIP MAPPING
11.3.1 VISIONARY LEADERS
11.3.2 INNOVATORS
11.3.3 DYNAMIC DIFFERENTIATORS
11.3.4 EMERGING COMPANIES
11.4 COMPETITIVE SCENARIO
11.4.1 PRODUCT LAUNCHES & ENHANCEMENTS
11.4.2 FUNDING
11.4.3 ACQUISITIONS
11.4.4 PARTNERSHIPS
11.4.5 COLLABORATIONS
12 COMPANY PROFILES
(Business overview, Products offered, Recent developments, MNM view)*
12.1 ORACLE
12.2 MEDIDATA SOLUTIONS
12.3 PAREXEL (ACQUIRED BY PAMPLONA CAPITAL MANAGEMENT)
12.4 BIOCLINICA
12.5 BIO-OPTRONICS
12.6 IBM
12.7 DATATRAK
12.8 VEEVA SYSTEMS
12.9 DSG
12.10 MASTERCONTROL
12.11 ERT
12.12 FORTE RESEARCH SYSTEMS
12.13 MEDNET SOLUTIONS
12.14 ARISGLOBAL
12.15 ANJU SOFTWARE
12.16 AXISIT
12.17 TECHSOL CORPORATION
12.18 OPENCLINICA
12.19 CRF HEALTH
12.20 COVANCE INC.
*Business overview, Products offered, Recent developments, MNM view might not be captured in case of unlisted companies.
13 APPENDIX
13.1 DISCUSSION GUIDE
13.2 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
13.3 AVAILABLE CUSTOMIZATIONS
13.4 RELATED REPORTS
13.5 AUTHOR DETAILS
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.2.1 MARKET SCOPE
1.2.2 MARKETS COVERED
1.2.3 YEARS CONSIDERED FOR THE STUDY
1.3 CURRENCY
1.4 LIMITATIONS
1.5 STAKEHOLDERS
2 RESEARCH METHODOLOGY
2.1 RESEARCH DATA
2.1.1 SECONDARY DATA
2.1.1.1 Secondary sources
2.1.2 PRIMARY DATA
2.1.2.1 Primary sources
2.1.3 MARKET SIZE ESTIMATION METHODOLOGY
2.1.4 REVENUE MAPPING-BASED MARKET ESTIMATION (APPROACH 1)
2.1.5 MARKET ESTIMATION USING PARENT MARKET SIZE (APPROACH 2)
2.2 MARKET DATA ESTIMATION AND TRIANGULATION
2.3 ASSUMPTIONS OF THE STUDY
3 EXECUTIVE SUMMARY
4 PREMIUM INSIGHTS
4.1 RISK-BASED MONITORING SOFTWARE: MARKET OVERVIEW
4.2 RISK-BASED MONITORING SOFTWARE MARKET SHARE, BY TYPE, 2020 VS. 2025
4.3 RISK-BASED MONITORING SOFTWARE MARKET SHARE, BY COMPONENT, 2020 VS. 2025
4.4 RISK-BASED MONITORING SOFTWARE MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES
5 MARKET OVERVIEW
5.1 INTRODUCTION
5.2 MARKET DYNAMICS
5.2.1 DRIVERS
5.2.1.1 Cost and time efficiency of RBM solutions
5.2.1.2 Rising number of clinical trials
5.2.1.3 Increasing government funding and grants to support clinical trials
5.2.2 RESTRAINTS
5.2.2.1 High implementation costs
5.2.3 OPPORTUNITIES
5.2.3.1 Increased outsourcing of clinical trial processes to CROs
5.2.4 CHALLENGES
5.2.4.1 Dearth of skilled professionals for operating RBM solutions
6 RISK-BASED MONITORING SOFTWARE MARKET, BY TYPE
6.1 INTRODUCTION
6.2 ENTERPRISE RBM SOFTWARE
6.2.1 ENTERPRISE RBM SOFTWARE DOMINATES THE RBM SOFTWARE MARKET
6.3 SITE RBM SOFTWARE
6.3.1 SITE RBM SOFTWARE OFFERS IMPROVED TRIAL MANAGEMENT
7 RISK-BASED MONITORING SOFTWARE MARKET, BY COMPONENT
7.1 INTRODUCTION
7.2 SOFTWARE
7.2.1 GROWING ADOPTION OF CLINICAL TRIAL MANAGEMENT SOLUTIONS TO SUPPORT MARKET GROWTH
7.3 SERVICES
7.3.1 NEED FOR CONTINUOUS UPGRADE OF RBM SOFTWARE PRODUCTS HAS INCREASED THE DEMAND FOR SERVICES
8 RISK-BASED MONITORING SOFTWARE MARKET, BY DELIVERY MODE
8.1 INTRODUCTION
8.2 WEB-BASED (ON-DEMAND)
8.2.1 ADVANTAGES SUCH AS EASY ACCESS & REDUCTION IN COSTS TO SUPPORT MARKET GROWTH
8.3 LICENSED ENTERPRISE (ON-PREMISE)
8.3.1 ON-PREMISE MODELS MINIMIZE RISKS ASSOCIATED WITH DATA BREACHES AND EXTERNAL ATTACKS
8.4 CLOUD-BASED (SAAS)
8.4.1 INCREASING ADOPTION OF CLOUD-BASED SOLUTIONS TO DRIVE MARKET GROWTH
9 RISK-BASED MONITORING SOFTWARE MARKET, BY END USER
9.1 INTRODUCTION
9.2 PHARMACEUTICAL & BIOPHARMACEUTICAL COMPANIES
9.2.1 INCREASED PHARMACEUTICAL R&D SPENDING TO DRIVE MARKET GROWTH
9.3 CONTRACT RESEARCH ORGANIZATIONS (CROS)
9.3.1 INCREASING OUTSOURCING OF CLINICAL RESEARCH ACTIVITIES
BY PHARMACEUTICAL, BIOTECHNOLOGY, AND MEDICAL DEVICE COMPANIES TO DRIVE MARKET GROWTH
9.4 MEDICAL DEVICE COMPANIES
9.4.1 GOVERNMENT FUNDING TO SUPPORT MARKET GROWTH
9.5 OTHER END USERS
10 RISK-BASED MONITORING SOFTWARE MARKET, BY REGION
10.1 INTRODUCTION
10.2 NORTH AMERICA
10.2.1 US
10.2.1.1 The US holds the largest share of the North American market
10.2.2 CANADA
10.2.2.1 Government funding to boost market growth
10.3 EUROPE
10.3.1 GERMANY
10.3.1.1 Initiatives to boost digital health to propel market growth
10.3.2 UK
10.3.2.1 Favorable R&D scenario in the country to boost the adoption of
RBM software
10.3.3 FRANCE
10.3.3.1 Lack of sufficient funding to restrain market growth in France
10.3.4 ROE
10.4 APAC
10.4.1 CHINA
10.4.1.1 Increased pharmaceutical R&D spending to drive market growth
10.4.2 JAPAN
10.4.2.1 Stringent regulatory scenario in Japan to restrain market growth
10.4.3 INDIA
10.4.3.1 Favorable pharmaceutical R&D scenario to drive the adoption of RBM software
10.4.4 REST OF ASIA PACIFIC
10.5 REST OF THE WORLD
11 COMPETITIVE LANDSCAPE
11.1 OVERVIEW
11.2 MARKET SHARE ANALYSIS
11.3 COMPETITIVE LEADERSHIP MAPPING
11.3.1 VISIONARY LEADERS
11.3.2 INNOVATORS
11.3.3 DYNAMIC DIFFERENTIATORS
11.3.4 EMERGING COMPANIES
11.4 COMPETITIVE SCENARIO
11.4.1 PRODUCT LAUNCHES & ENHANCEMENTS
11.4.2 FUNDING
11.4.3 ACQUISITIONS
11.4.4 PARTNERSHIPS
11.4.5 COLLABORATIONS
12 COMPANY PROFILES
(Business overview, Products offered, Recent developments, MNM view)*
12.1 ORACLE
12.2 MEDIDATA SOLUTIONS
12.3 PAREXEL (ACQUIRED BY PAMPLONA CAPITAL MANAGEMENT)
12.4 BIOCLINICA
12.5 BIO-OPTRONICS
12.6 IBM
12.7 DATATRAK
12.8 VEEVA SYSTEMS
12.9 DSG
12.10 MASTERCONTROL
12.11 ERT
12.12 FORTE RESEARCH SYSTEMS
12.13 MEDNET SOLUTIONS
12.14 ARISGLOBAL
12.15 ANJU SOFTWARE
12.16 AXISIT
12.17 TECHSOL CORPORATION
12.18 OPENCLINICA
12.19 CRF HEALTH
12.20 COVANCE INC.
*Business overview, Products offered, Recent developments, MNM view might not be captured in case of unlisted companies.
13 APPENDIX
13.1 DISCUSSION GUIDE
13.2 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
13.3 AVAILABLE CUSTOMIZATIONS
13.4 RELATED REPORTS
13.5 AUTHOR DETAILS
LIST OF TABLES
TABLE 1 NUMBER OF REGISTERED CLINICAL TRIAL STUDIES GLOBALLY, 2002–2019
TABLE 2 RISK-BASED MONITORING SOFTWARE MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 3 ENTERPRISE RBM SOFTWARE MARKET, BY REGION, 2018–2025 (USD MILLION)
TABLE 4 NORTH AMERICA: ENTERPRISE RBM SOFTWARE MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 5 EUROPE: ENTERPRISE RBM SOFTWARE MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 6 ASIA PACIFIC: ENTERPRISE RBM SOFTWARE MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 7 SITE RBM SOFTWARE MARKET, BY REGION, 2018–2025 (USD MILLION)
TABLE 8 NORTH AMERICA: SITE RBM SOFTWARE MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 9 EUROPE: SITE RBM SOFTWARE MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 10 ASIA PACIFIC: SITE RBM SOFTWARE MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 11 RISK-BASED MONITORING SOFTWARE MARKET, BY COMPONENT, 2018–2025 (USD MILLION)
TABLE 12 RISK-BASED MONITORING SOFTWARE MARKET FOR SOFTWARE, BY REGION, 2018–2025 (USD MILLION)
TABLE 13 NORTH AMERICA: RISK-BASED MONITORING SOFTWARE MARKET FOR SOFTWARE, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 14 EUROPE: RISK-BASED MONITORING SOFTWARE MARKET FOR SOFTWARE, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 15 ASIA PACIFIC: RISK-BASED MONITORING SOFTWARE MARKET FOR SOFTWARE, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 16 RISK-BASED MONITORING SOFTWARE MARKET FOR SERVICES, BY REGION, 2018–2025 (USD MILLION)
TABLE 17 NORTH AMERICA: RISK-BASED MONITORING SOFTWARE MARKET FOR SERVICES, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 18 EUROPE: RISK-BASED MONITORING SOFTWARE MARKET FOR SERVICES, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 19 ASIA PACIFIC: RISK-BASED MONITORING SOFTWARE MARKET FOR SERVICES, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 20 RISK-BASED MONITORING SOFTWARE MARKET, BY DELIVERY MODE, 2018–2025 (USD MILLION)
TABLE 21 RISK-BASED MONITORING SOFTWARE MARKET FOR WEB-BASED DELIVERY, BY REGION, 2018–2025 (USD MILLION)
TABLE 22 NORTH AMERICA: RISK-BASED MONITORING SOFTWARE MARKET FOR WEB-BASED DELIVERY, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 23 EUROPE: RISK-BASED MONITORING SOFTWARE MARKET FOR WEB-BASED DELIVERY, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 24 ASIA PACIFIC: RISK-BASED MONITORING SOFTWARE MARKET FOR WEB-BASED DELIVERY, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 25 RISK-BASED MONITORING SOFTWARE MARKET FOR LICENSED ENTERPRISE DELIVERY, BY REGION, 2018–2025 (USD MILLION)
TABLE 26 NORTH AMERICA: RISK-BASED MONITORING SOFTWARE MARKET FOR LICENSED ENTERPRISE DELIVERY, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 27 EUROPE: RISK-BASED MONITORING SOFTWARE MARKET FOR LICENSED ENTERPRISE DELIVERY, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 28 ASIA PACIFIC: RISK-BASED MONITORING SOFTWARE MARKET FOR LICENSED ENTERPRISE DELIVERY, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 29 RISK-BASED MONITORING SOFTWARE MARKET FOR CLOUD-BASED DELIVERY, BY REGION, 2018–2025 (USD MILLION)
TABLE 30 NORTH AMERICA: RISK-BASED MONITORING SOFTWARE MARKET FOR
CLOUD-BASED DELIVERY, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 31 EUROPE: RISK-BASED MONITORING SOFTWARE MARKET FOR CLOUD-BASED DELIVERY, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 32 ASIA PACIFIC: RISK-BASED MONITORING SOFTWARE MARKET FOR CLOUD-BASED DELIVERY, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 33 RISK-BASED MONITORING SOFTWARE MARKET, BY END USER, 2018–2025 (USD MILLION)
TABLE 34 RISK-BASED MONITORING SOFTWARE MARKET FOR PHARMACEUTICAL & BIOPHARMACEUTICAL COMPANIES, BY REGION, 2018–2025 (USD MILLION)
TABLE 35 NORTH AMERICA: RISK-BASED MONITORING SOFTWARE MARKET FOR PHARMACEUTICAL & BIOPHARMACEUTICAL COMPANIES, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 36 EUROPE: RISK-BASED MONITORING SOFTWARE MARKET FOR PHARMACEUTICAL & BIOPHARMACEUTICAL COMPANIES, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 37 ASIA PACIFIC: RISK-BASED MONITORING SOFTWARE MARKET FOR PHARMACEUTICAL & BIOPHARMACEUTICAL COMPANIES, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 38 RISK-BASED MONITORING SOFTWARE MARKET FOR CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2018–2025 (USD MILLION)
TABLE 39 NORTH AMERICA: RISK-BASED MONITORING SOFTWARE MARKET FOR CONTRACT RESEARCH ORGANIZATIONS, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 40 EUROPE: RISK-BASED MONITORING SOFTWARE MARKET FOR CONTRACT RESEARCH ORGANIZATIONS, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 41 ASIA PACIFIC: RISK-BASED MONITORING SOFTWARE MARKET FOR CONTRACT RESEARCH ORGANIZATIONS, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 42 RISK-BASED MONITORING SOFTWARE MARKET FOR MEDICAL DEVICE COMPANIES, BY REGION, 2018–2025 (USD MILLION)
TABLE 43 NORTH AMERICA: RISK-BASED MONITORING SOFTWARE MARKET FOR MEDICAL DEVICE COMPANIES, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 44 EUROPE: RISK-BASED MONITORING SOFTWARE MARKET FOR MEDICAL DEVICE COMPANIES, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 45 ASIA PACIFIC: RISK-BASED MONITORING SOFTWARE MARKET FOR MEDICAL DEVICE COMPANIES, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 46 RISK-BASED MONITORING SOFTWARE MARKET FOR OTHER END USERS, BY REGION, 2018–2025 (USD MILLION)
TABLE 47 NORTH AMERICA: RISK-BASED MONITORING SOFTWARE MARKET FOR
OTHER END USERS, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 48 EUROPE: RISK-BASED MONITORING SOFTWARE MARKET FOR OTHER
END USERS, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 49 ASIA PACIFIC: RISK-BASED MONITORING SOFTWARE MARKET FOR OTHER
END USERS, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 50 RISK-BASED MONITORING SOFTWARE MARKET, BY REGION, 2018–2025 (USD MILLION)
TABLE 51 NORTH AMERICA: RISK-BASED MONITORING SOFTWARE MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 52 NORTH AMERICA: RISK-BASED MONITORING SOFTWARE MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 53 NORTH AMERICA: RISK-BASED MONITORING SOFTWARE MARKET, BY COMPONENT, 2018–2025 (USD MILLION)
TABLE 54 NORTH AMERICA: RISK-BASED MONITORING SOFTWARE MARKET, BY DELIVERY MODE, 2018–2025 (USD MILLION)
TABLE 55 NORTH AMERICA: RISK-BASED MONITORING SOFTWARE MARKET, BY END USER, 2018–2025 (USD MILLION)
TABLE 56 US: RISK-BASED MONITORING SOFTWARE MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 57 US: RISK-BASED MONITORING SOFTWARE MARKET, BY COMPONENT, 2018–2025 (USD MILLION)
TABLE 58 US: RISK-BASED MONITORING SOFTWARE MARKET, BY DELIVERY MODE, 2018–2025 (USD MILLION)
TABLE 59 US: RISK-BASED MONITORING SOFTWARE MARKET, BY END USER, 2018–2025 (USD MILLION)
TABLE 60 CANADA: RISK-BASED MONITORING SOFTWARE MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 61 CANADA: RISK-BASED MONITORING SOFTWARE MARKET, BY COMPONENT, 2018–2025 (USD MILLION)
TABLE 62 CANADA: RISK-BASED MONITORING SOFTWARE MARKET, BY DELIVERY MODE, 2018–2025 (USD MILLION)
TABLE 63 CANADA: RISK-BASED MONITORING SOFTWARE MARKET, BY END USER, 2018–2025 (USD MILLION)
TABLE 64 EUROPE: RISK-BASED MONITORING SOFTWARE MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 65 EUROPE: RISK-BASED MONITORING SOFTWARE MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 66 EUROPE: RISK-BASED MONITORING SOFTWARE MARKET, BY COMPONENT, 2018–2025 (USD MILLION)
TABLE 67 EUROPE: RISK-BASED MONITORING SOFTWARE MARKET, BY DELIVERY MODE, 2018–2025 (USD MILLION)
TABLE 68 EUROPE: RISK-BASED MONITORING SOFTWARE MARKET, BY END USER, 2018–2025 (USD MILLION)
TABLE 69 GERMANY: RISK-BASED MONITORING SOFTWARE MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 70 GERMANY: RISK-BASED MONITORING SOFTWARE MARKET, BY COMPONENT, 2018–2025 (USD MILLION)
TABLE 71 GERMANY: RISK-BASED MONITORING SOFTWARE MARKET, BY DELIVERY MODE, 2018–2025 (USD MILLION)
TABLE 72 GERMANY: RISK-BASED MONITORING SOFTWARE MARKET, BY END USER, 2018–2025 (USD MILLION)
TABLE 73 UK: RISK-BASED MONITORING SOFTWARE MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 74 UK: RISK-BASED MONITORING SOFTWARE MARKET, BY COMPONENT, 2018–2025 (USD MILLION)
TABLE 75 UK: RISK-BASED MONITORING SOFTWARE MARKET, BY DELIVERY MODE, 2018–2025 (USD MILLION)
TABLE 76 UK: RISK-BASED MONITORING SOFTWARE MARKET, BY END USER, 2018–2025 (USD MILLION)
TABLE 77 FRANCE: RISK-BASED MONITORING SOFTWARE MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 78 FRANCE: RISK-BASED MONITORING SOFTWARE MARKET, BY COMPONENT, 2018–2025 (USD MILLION)
TABLE 79 FRANCE: RISK-BASED MONITORING SOFTWARE MARKET, BY DELIVERY MODE, 2018–2025 (USD MILLION)
TABLE 80 FRANCE: RISK-BASED MONITORING SOFTWARE MARKET, BY END USER, 2018–2025 (USD MILLION)
TABLE 81 ROE: RISK-BASED MONITORING SOFTWARE MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 82 ROE: RISK-BASED MONITORING SOFTWARE MARKET, BY COMPONENT, 2018–2025 (USD MILLION)
TABLE 83 ROE: RISK-BASED MONITORING SOFTWARE MARKET, BY DELIVERY MODE, 2018–2025 (USD MILLION)
TABLE 84 ROE: RISK-BASED MONITORING SOFTWARE MARKET, BY END USER, 2018–2025 (USD MILLION)
TABLE 85 ASIA PACIFIC: RISK-BASED MONITORING SOFTWARE MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 86 ASIA PACIFIC: RISK-BASED MONITORING SOFTWARE MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 87 ASIA PACIFIC: RISK-BASED MONITORING SOFTWARE MARKET, BY COMPONENT, 2018–2025 (USD MILLION)
TABLE 88 ASIA PACIFIC: RISK-BASED MONITORING SOFTWARE MARKET, BY DELIVERY MODE, 2018–2025 (USD MILLION)
TABLE 89 ASIA PACIFIC: RISK-BASED MONITORING SOFTWARE MARKET, BY END USER, 2018–2025 (USD MILLION)
TABLE 90 CHINA: RISK-BASED MONITORING SOFTWARE MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 91 CHINA: RISK-BASED MONITORING SOFTWARE MARKET, BY COMPONENT, 2018–2025 (USD MILLION)
TABLE 92 CHINA: RISK-BASED MONITORING SOFTWARE MARKET, BY DELIVERY MODE, 2018–2025 (USD MILLION)
TABLE 93 CHINA: RISK-BASED MONITORING SOFTWARE MARKET, BY END USER, 2018–2025 (USD MILLION)
TABLE 94 JAPAN: RISK-BASED MONITORING SOFTWARE MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 95 JAPAN: RISK-BASED MONITORING SOFTWARE MARKET, BY COMPONENT, 2018–2025 (USD MILLION)
TABLE 96 JAPAN: RISK-BASED MONITORING SOFTWARE MARKET, BY DELIVERY MODE, 2018–2025 (USD MILLION)
TABLE 97 JAPAN: RISK-BASED MONITORING SOFTWARE MARKET, BY END USER, 2018–2025 (USD MILLION)
TABLE 98 INDIA: RISK-BASED MONITORING SOFTWARE MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 99 INDIA: RISK-BASED MONITORING SOFTWARE MARKET, BY COMPONENT, 2018–2025 (USD MILLION)
TABLE 100 INDIA: RISK-BASED MONITORING SOFTWARE MARKET, BY DELIVERY MODE, 2018–2025 (USD MILLION)
TABLE 101 INDIA: RISK-BASED MONITORING SOFTWARE MARKET, BY END USER, 2018–2025 (USD MILLION)
TABLE 102 ROAPAC: RISK-BASED MONITORING SOFTWARE MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 103 ROAPAC: RISK-BASED MONITORING SOFTWARE MARKET, BY COMPONENT, 2018–2025 (USD MILLION)
TABLE 104 ROAPAC: RISK-BASED MONITORING SOFTWARE MARKET, BY DELIVERY MODE, 2018–2025 (USD MILLION)
TABLE 105 ROAPAC: RISK-BASED MONITORING SOFTWARE MARKET, BY END USER, 2018–2025 (USD MILLION)
TABLE 106 ROW: RISK-BASED MONITORING SOFTWARE MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 107 ROW: RISK-BASED MONITORING SOFTWARE MARKET, BY COMPONENT, 2018–2025 (USD MILLION)
TABLE 108 ROW: RISK-BASED MONITORING SOFTWARE MARKET, BY DELIVERY MODE, 2018–2025 (USD MILLION)
TABLE 109 ROW: RISK-BASED MONITORING SOFTWARE MARKET, BY END USER, 2018–2025 (USD MILLION)
TABLE 110 KEY PRODUCT LAUNCHES & ENHANCEMENTS
TABLE 111 KEY FUNDING
TABLE 112 KEY ACQUISITIONS
TABLE 113 KEY PARTNERSHIPS
TABLE 114 KEY COLLABORATIONS
TABLE 1 NUMBER OF REGISTERED CLINICAL TRIAL STUDIES GLOBALLY, 2002–2019
TABLE 2 RISK-BASED MONITORING SOFTWARE MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 3 ENTERPRISE RBM SOFTWARE MARKET, BY REGION, 2018–2025 (USD MILLION)
TABLE 4 NORTH AMERICA: ENTERPRISE RBM SOFTWARE MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 5 EUROPE: ENTERPRISE RBM SOFTWARE MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 6 ASIA PACIFIC: ENTERPRISE RBM SOFTWARE MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 7 SITE RBM SOFTWARE MARKET, BY REGION, 2018–2025 (USD MILLION)
TABLE 8 NORTH AMERICA: SITE RBM SOFTWARE MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 9 EUROPE: SITE RBM SOFTWARE MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 10 ASIA PACIFIC: SITE RBM SOFTWARE MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 11 RISK-BASED MONITORING SOFTWARE MARKET, BY COMPONENT, 2018–2025 (USD MILLION)
TABLE 12 RISK-BASED MONITORING SOFTWARE MARKET FOR SOFTWARE, BY REGION, 2018–2025 (USD MILLION)
TABLE 13 NORTH AMERICA: RISK-BASED MONITORING SOFTWARE MARKET FOR SOFTWARE, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 14 EUROPE: RISK-BASED MONITORING SOFTWARE MARKET FOR SOFTWARE, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 15 ASIA PACIFIC: RISK-BASED MONITORING SOFTWARE MARKET FOR SOFTWARE, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 16 RISK-BASED MONITORING SOFTWARE MARKET FOR SERVICES, BY REGION, 2018–2025 (USD MILLION)
TABLE 17 NORTH AMERICA: RISK-BASED MONITORING SOFTWARE MARKET FOR SERVICES, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 18 EUROPE: RISK-BASED MONITORING SOFTWARE MARKET FOR SERVICES, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 19 ASIA PACIFIC: RISK-BASED MONITORING SOFTWARE MARKET FOR SERVICES, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 20 RISK-BASED MONITORING SOFTWARE MARKET, BY DELIVERY MODE, 2018–2025 (USD MILLION)
TABLE 21 RISK-BASED MONITORING SOFTWARE MARKET FOR WEB-BASED DELIVERY, BY REGION, 2018–2025 (USD MILLION)
TABLE 22 NORTH AMERICA: RISK-BASED MONITORING SOFTWARE MARKET FOR WEB-BASED DELIVERY, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 23 EUROPE: RISK-BASED MONITORING SOFTWARE MARKET FOR WEB-BASED DELIVERY, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 24 ASIA PACIFIC: RISK-BASED MONITORING SOFTWARE MARKET FOR WEB-BASED DELIVERY, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 25 RISK-BASED MONITORING SOFTWARE MARKET FOR LICENSED ENTERPRISE DELIVERY, BY REGION, 2018–2025 (USD MILLION)
TABLE 26 NORTH AMERICA: RISK-BASED MONITORING SOFTWARE MARKET FOR LICENSED ENTERPRISE DELIVERY, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 27 EUROPE: RISK-BASED MONITORING SOFTWARE MARKET FOR LICENSED ENTERPRISE DELIVERY, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 28 ASIA PACIFIC: RISK-BASED MONITORING SOFTWARE MARKET FOR LICENSED ENTERPRISE DELIVERY, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 29 RISK-BASED MONITORING SOFTWARE MARKET FOR CLOUD-BASED DELIVERY, BY REGION, 2018–2025 (USD MILLION)
TABLE 30 NORTH AMERICA: RISK-BASED MONITORING SOFTWARE MARKET FOR
CLOUD-BASED DELIVERY, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 31 EUROPE: RISK-BASED MONITORING SOFTWARE MARKET FOR CLOUD-BASED DELIVERY, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 32 ASIA PACIFIC: RISK-BASED MONITORING SOFTWARE MARKET FOR CLOUD-BASED DELIVERY, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 33 RISK-BASED MONITORING SOFTWARE MARKET, BY END USER, 2018–2025 (USD MILLION)
TABLE 34 RISK-BASED MONITORING SOFTWARE MARKET FOR PHARMACEUTICAL & BIOPHARMACEUTICAL COMPANIES, BY REGION, 2018–2025 (USD MILLION)
TABLE 35 NORTH AMERICA: RISK-BASED MONITORING SOFTWARE MARKET FOR PHARMACEUTICAL & BIOPHARMACEUTICAL COMPANIES, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 36 EUROPE: RISK-BASED MONITORING SOFTWARE MARKET FOR PHARMACEUTICAL & BIOPHARMACEUTICAL COMPANIES, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 37 ASIA PACIFIC: RISK-BASED MONITORING SOFTWARE MARKET FOR PHARMACEUTICAL & BIOPHARMACEUTICAL COMPANIES, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 38 RISK-BASED MONITORING SOFTWARE MARKET FOR CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2018–2025 (USD MILLION)
TABLE 39 NORTH AMERICA: RISK-BASED MONITORING SOFTWARE MARKET FOR CONTRACT RESEARCH ORGANIZATIONS, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 40 EUROPE: RISK-BASED MONITORING SOFTWARE MARKET FOR CONTRACT RESEARCH ORGANIZATIONS, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 41 ASIA PACIFIC: RISK-BASED MONITORING SOFTWARE MARKET FOR CONTRACT RESEARCH ORGANIZATIONS, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 42 RISK-BASED MONITORING SOFTWARE MARKET FOR MEDICAL DEVICE COMPANIES, BY REGION, 2018–2025 (USD MILLION)
TABLE 43 NORTH AMERICA: RISK-BASED MONITORING SOFTWARE MARKET FOR MEDICAL DEVICE COMPANIES, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 44 EUROPE: RISK-BASED MONITORING SOFTWARE MARKET FOR MEDICAL DEVICE COMPANIES, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 45 ASIA PACIFIC: RISK-BASED MONITORING SOFTWARE MARKET FOR MEDICAL DEVICE COMPANIES, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 46 RISK-BASED MONITORING SOFTWARE MARKET FOR OTHER END USERS, BY REGION, 2018–2025 (USD MILLION)
TABLE 47 NORTH AMERICA: RISK-BASED MONITORING SOFTWARE MARKET FOR
OTHER END USERS, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 48 EUROPE: RISK-BASED MONITORING SOFTWARE MARKET FOR OTHER
END USERS, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 49 ASIA PACIFIC: RISK-BASED MONITORING SOFTWARE MARKET FOR OTHER
END USERS, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 50 RISK-BASED MONITORING SOFTWARE MARKET, BY REGION, 2018–2025 (USD MILLION)
TABLE 51 NORTH AMERICA: RISK-BASED MONITORING SOFTWARE MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 52 NORTH AMERICA: RISK-BASED MONITORING SOFTWARE MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 53 NORTH AMERICA: RISK-BASED MONITORING SOFTWARE MARKET, BY COMPONENT, 2018–2025 (USD MILLION)
TABLE 54 NORTH AMERICA: RISK-BASED MONITORING SOFTWARE MARKET, BY DELIVERY MODE, 2018–2025 (USD MILLION)
TABLE 55 NORTH AMERICA: RISK-BASED MONITORING SOFTWARE MARKET, BY END USER, 2018–2025 (USD MILLION)
TABLE 56 US: RISK-BASED MONITORING SOFTWARE MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 57 US: RISK-BASED MONITORING SOFTWARE MARKET, BY COMPONENT, 2018–2025 (USD MILLION)
TABLE 58 US: RISK-BASED MONITORING SOFTWARE MARKET, BY DELIVERY MODE, 2018–2025 (USD MILLION)
TABLE 59 US: RISK-BASED MONITORING SOFTWARE MARKET, BY END USER, 2018–2025 (USD MILLION)
TABLE 60 CANADA: RISK-BASED MONITORING SOFTWARE MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 61 CANADA: RISK-BASED MONITORING SOFTWARE MARKET, BY COMPONENT, 2018–2025 (USD MILLION)
TABLE 62 CANADA: RISK-BASED MONITORING SOFTWARE MARKET, BY DELIVERY MODE, 2018–2025 (USD MILLION)
TABLE 63 CANADA: RISK-BASED MONITORING SOFTWARE MARKET, BY END USER, 2018–2025 (USD MILLION)
TABLE 64 EUROPE: RISK-BASED MONITORING SOFTWARE MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 65 EUROPE: RISK-BASED MONITORING SOFTWARE MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 66 EUROPE: RISK-BASED MONITORING SOFTWARE MARKET, BY COMPONENT, 2018–2025 (USD MILLION)
TABLE 67 EUROPE: RISK-BASED MONITORING SOFTWARE MARKET, BY DELIVERY MODE, 2018–2025 (USD MILLION)
TABLE 68 EUROPE: RISK-BASED MONITORING SOFTWARE MARKET, BY END USER, 2018–2025 (USD MILLION)
TABLE 69 GERMANY: RISK-BASED MONITORING SOFTWARE MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 70 GERMANY: RISK-BASED MONITORING SOFTWARE MARKET, BY COMPONENT, 2018–2025 (USD MILLION)
TABLE 71 GERMANY: RISK-BASED MONITORING SOFTWARE MARKET, BY DELIVERY MODE, 2018–2025 (USD MILLION)
TABLE 72 GERMANY: RISK-BASED MONITORING SOFTWARE MARKET, BY END USER, 2018–2025 (USD MILLION)
TABLE 73 UK: RISK-BASED MONITORING SOFTWARE MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 74 UK: RISK-BASED MONITORING SOFTWARE MARKET, BY COMPONENT, 2018–2025 (USD MILLION)
TABLE 75 UK: RISK-BASED MONITORING SOFTWARE MARKET, BY DELIVERY MODE, 2018–2025 (USD MILLION)
TABLE 76 UK: RISK-BASED MONITORING SOFTWARE MARKET, BY END USER, 2018–2025 (USD MILLION)
TABLE 77 FRANCE: RISK-BASED MONITORING SOFTWARE MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 78 FRANCE: RISK-BASED MONITORING SOFTWARE MARKET, BY COMPONENT, 2018–2025 (USD MILLION)
TABLE 79 FRANCE: RISK-BASED MONITORING SOFTWARE MARKET, BY DELIVERY MODE, 2018–2025 (USD MILLION)
TABLE 80 FRANCE: RISK-BASED MONITORING SOFTWARE MARKET, BY END USER, 2018–2025 (USD MILLION)
TABLE 81 ROE: RISK-BASED MONITORING SOFTWARE MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 82 ROE: RISK-BASED MONITORING SOFTWARE MARKET, BY COMPONENT, 2018–2025 (USD MILLION)
TABLE 83 ROE: RISK-BASED MONITORING SOFTWARE MARKET, BY DELIVERY MODE, 2018–2025 (USD MILLION)
TABLE 84 ROE: RISK-BASED MONITORING SOFTWARE MARKET, BY END USER, 2018–2025 (USD MILLION)
TABLE 85 ASIA PACIFIC: RISK-BASED MONITORING SOFTWARE MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 86 ASIA PACIFIC: RISK-BASED MONITORING SOFTWARE MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 87 ASIA PACIFIC: RISK-BASED MONITORING SOFTWARE MARKET, BY COMPONENT, 2018–2025 (USD MILLION)
TABLE 88 ASIA PACIFIC: RISK-BASED MONITORING SOFTWARE MARKET, BY DELIVERY MODE, 2018–2025 (USD MILLION)
TABLE 89 ASIA PACIFIC: RISK-BASED MONITORING SOFTWARE MARKET, BY END USER, 2018–2025 (USD MILLION)
TABLE 90 CHINA: RISK-BASED MONITORING SOFTWARE MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 91 CHINA: RISK-BASED MONITORING SOFTWARE MARKET, BY COMPONENT, 2018–2025 (USD MILLION)
TABLE 92 CHINA: RISK-BASED MONITORING SOFTWARE MARKET, BY DELIVERY MODE, 2018–2025 (USD MILLION)
TABLE 93 CHINA: RISK-BASED MONITORING SOFTWARE MARKET, BY END USER, 2018–2025 (USD MILLION)
TABLE 94 JAPAN: RISK-BASED MONITORING SOFTWARE MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 95 JAPAN: RISK-BASED MONITORING SOFTWARE MARKET, BY COMPONENT, 2018–2025 (USD MILLION)
TABLE 96 JAPAN: RISK-BASED MONITORING SOFTWARE MARKET, BY DELIVERY MODE, 2018–2025 (USD MILLION)
TABLE 97 JAPAN: RISK-BASED MONITORING SOFTWARE MARKET, BY END USER, 2018–2025 (USD MILLION)
TABLE 98 INDIA: RISK-BASED MONITORING SOFTWARE MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 99 INDIA: RISK-BASED MONITORING SOFTWARE MARKET, BY COMPONENT, 2018–2025 (USD MILLION)
TABLE 100 INDIA: RISK-BASED MONITORING SOFTWARE MARKET, BY DELIVERY MODE, 2018–2025 (USD MILLION)
TABLE 101 INDIA: RISK-BASED MONITORING SOFTWARE MARKET, BY END USER, 2018–2025 (USD MILLION)
TABLE 102 ROAPAC: RISK-BASED MONITORING SOFTWARE MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 103 ROAPAC: RISK-BASED MONITORING SOFTWARE MARKET, BY COMPONENT, 2018–2025 (USD MILLION)
TABLE 104 ROAPAC: RISK-BASED MONITORING SOFTWARE MARKET, BY DELIVERY MODE, 2018–2025 (USD MILLION)
TABLE 105 ROAPAC: RISK-BASED MONITORING SOFTWARE MARKET, BY END USER, 2018–2025 (USD MILLION)
TABLE 106 ROW: RISK-BASED MONITORING SOFTWARE MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 107 ROW: RISK-BASED MONITORING SOFTWARE MARKET, BY COMPONENT, 2018–2025 (USD MILLION)
TABLE 108 ROW: RISK-BASED MONITORING SOFTWARE MARKET, BY DELIVERY MODE, 2018–2025 (USD MILLION)
TABLE 109 ROW: RISK-BASED MONITORING SOFTWARE MARKET, BY END USER, 2018–2025 (USD MILLION)
TABLE 110 KEY PRODUCT LAUNCHES & ENHANCEMENTS
TABLE 111 KEY FUNDING
TABLE 112 KEY ACQUISITIONS
TABLE 113 KEY PARTNERSHIPS
TABLE 114 KEY COLLABORATIONS
LIST OF FIGURES
FIGURE 1 RESEARCH DESIGN
FIGURE 2 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
FIGURE 3 RESEARCH METHODOLOGY: HYPOTHESIS BUILDING
FIGURE 4 MARKET SIZE ESTIMATION: REVENUE SHARE ANALYSIS (1/2)
FIGURE 5 MARKET SIZE ESTIMATION: REVENUE SHARE ANALYSIS (2/2)
FIGURE 6 MARKET SIZE ESTIMATION BASED ON PARENT MARKET SIZE (APPROACH 2)
FIGURE 7 DATA TRIANGULATION METHODOLOGY
FIGURE 8 RISK-BASED MONITORING SOFTWARE MARKET, BY TYPE, 2020 VS. 2025 (USD MILLION)
FIGURE 9 RISK-BASED MONITORING SOFTWARE MARKET, BY COMPONENT, 2020 VS. 2025 (USD MILLION)
FIGURE 10 RISK-BASED MONITORING SOFTWARE MARKET, BY DELIVERY MODE, 2020 VS. 2025 (USD MILLION)
FIGURE 11 RISK-BASED MONITORING SOFTWARE MARKET, BY END USER, 2020 VS. 2025 (USD MILLION)
FIGURE 12 GEOGRAPHICAL SNAPSHOT OF THE RISK-BASED MONITORING
SOFTWARE MARKET
FIGURE 13 RISING NUMBER OF CLINICAL TRIALS TO DRIVE MARKET GROWTH
FIGURE 14 ENTERPRISE RBM SOFTWARE SEGMENT WILL CONTINUE TO DOMINATE
THE RBM SOFTWARE MARKET IN 2025
FIGURE 15 SOFTWARE SEGMENT ACCOUNTED FOR THE LARGEST MARKET SHARE IN 2019
FIGURE 16 ASIA PACIFIC TO REGISTER THE HIGHEST GROWTH IN THE RBM SOFTWARE MARKET DURING THE FORECAST PERIOD
FIGURE 17 RISK-BASED MONITORING SOFTWARE MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, & CHALLENGES
FIGURE 18 NORTH AMERICA: RISK-BASED MONITORING SOFTWARE MARKET SNAPSHOT
FIGURE 19 EUROPE: RISK-BASED MONITORING SOFTWARE MARKET SNAPSHOT
FIGURE 20 APAC: RISK-BASED MONITORING SOFTWARE MARKET SNAPSHOT
FIGURE 21 ROW: RISK-BASED MONITORING SOFTWARE MARKET SNAPSHOT
FIGURE 22 KEY DEVELOPMENTS IN THE RISK-BASED MONITORING SOFTWARE MARKET
FIGURE 23 RISK-BASED MONITORING SOFTWARE MARKET SHARE ANALYSIS (2018)
FIGURE 24 RISK-BASED MONITORING SOFTWARE MARKET (GLOBAL): COMPETITIVE LEADERSHIP MAPPING, 2018
FIGURE 25 ORACLE: COMPANY SNAPSHOT (2018)
FIGURE 26 MEDIDATA SOLUTIONS: COMPANY SNAPSHOT (2018)
FIGURE 27 PAREXEL: COMPANY SNAPSHOT (2016)
FIGURE 28 IBM: COMPANY SNAPSHOT (2018)
FIGURE 29 DATATRAK: COMPANY SNAPSHOT (2018)
FIGURE 30 VEEVA SYSTEMS: COMPANY SNAPSHOT (2018)
FIGURE 1 RESEARCH DESIGN
FIGURE 2 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
FIGURE 3 RESEARCH METHODOLOGY: HYPOTHESIS BUILDING
FIGURE 4 MARKET SIZE ESTIMATION: REVENUE SHARE ANALYSIS (1/2)
FIGURE 5 MARKET SIZE ESTIMATION: REVENUE SHARE ANALYSIS (2/2)
FIGURE 6 MARKET SIZE ESTIMATION BASED ON PARENT MARKET SIZE (APPROACH 2)
FIGURE 7 DATA TRIANGULATION METHODOLOGY
FIGURE 8 RISK-BASED MONITORING SOFTWARE MARKET, BY TYPE, 2020 VS. 2025 (USD MILLION)
FIGURE 9 RISK-BASED MONITORING SOFTWARE MARKET, BY COMPONENT, 2020 VS. 2025 (USD MILLION)
FIGURE 10 RISK-BASED MONITORING SOFTWARE MARKET, BY DELIVERY MODE, 2020 VS. 2025 (USD MILLION)
FIGURE 11 RISK-BASED MONITORING SOFTWARE MARKET, BY END USER, 2020 VS. 2025 (USD MILLION)
FIGURE 12 GEOGRAPHICAL SNAPSHOT OF THE RISK-BASED MONITORING
SOFTWARE MARKET
FIGURE 13 RISING NUMBER OF CLINICAL TRIALS TO DRIVE MARKET GROWTH
FIGURE 14 ENTERPRISE RBM SOFTWARE SEGMENT WILL CONTINUE TO DOMINATE
THE RBM SOFTWARE MARKET IN 2025
FIGURE 15 SOFTWARE SEGMENT ACCOUNTED FOR THE LARGEST MARKET SHARE IN 2019
FIGURE 16 ASIA PACIFIC TO REGISTER THE HIGHEST GROWTH IN THE RBM SOFTWARE MARKET DURING THE FORECAST PERIOD
FIGURE 17 RISK-BASED MONITORING SOFTWARE MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, & CHALLENGES
FIGURE 18 NORTH AMERICA: RISK-BASED MONITORING SOFTWARE MARKET SNAPSHOT
FIGURE 19 EUROPE: RISK-BASED MONITORING SOFTWARE MARKET SNAPSHOT
FIGURE 20 APAC: RISK-BASED MONITORING SOFTWARE MARKET SNAPSHOT
FIGURE 21 ROW: RISK-BASED MONITORING SOFTWARE MARKET SNAPSHOT
FIGURE 22 KEY DEVELOPMENTS IN THE RISK-BASED MONITORING SOFTWARE MARKET
FIGURE 23 RISK-BASED MONITORING SOFTWARE MARKET SHARE ANALYSIS (2018)
FIGURE 24 RISK-BASED MONITORING SOFTWARE MARKET (GLOBAL): COMPETITIVE LEADERSHIP MAPPING, 2018
FIGURE 25 ORACLE: COMPANY SNAPSHOT (2018)
FIGURE 26 MEDIDATA SOLUTIONS: COMPANY SNAPSHOT (2018)
FIGURE 27 PAREXEL: COMPANY SNAPSHOT (2016)
FIGURE 28 IBM: COMPANY SNAPSHOT (2018)
FIGURE 29 DATATRAK: COMPANY SNAPSHOT (2018)
FIGURE 30 VEEVA SYSTEMS: COMPANY SNAPSHOT (2018)
